Ultrahuman launches Ring PRO, a smarter ring with better heart-rate signals, a longer 15-day battery life, and a PRO Charger that can store an additional 45 days of power.

Preorders are open with shipping expected in March, but the U.S. market remains blocked due to ongoing patent concerns with Oura, though potential workarounds could enable a U.S. release later.

Ultrahuman debuts Jade, an AI health advisory LLM built for the Ultrahuman app, designed to keep data on secure, compliant servers and avoid generic models to reduce privacy risks and improve contextual accuracy.

Industry and media coverage is mounting around the patent dispute and Ultrahuman’s responses, signaling significant attention from major tech and business outlets.

The U.S. availability issue reflects a broader patent battle, with Ultrahuman previously found infringing on Oura’s form-factor patents and Oura pursuing litigation with other brands.

There is discussion of potential future UK availability for reviews as the U.S. restrictions persist.

Growth markets include the United Kingdom, Canada, Australia, and India, with India contributing roughly 8–9% of revenue after local investments.

Overall revenue is bolstered by growth in the UK, Canada, Australia, and India, with India representing about 8–9% of sales after local support investments.

Wareable’s coverage provides context on the brand and emphasizes its review-oriented, expert stance in the wearables space.

Women account for about 68% of Ultrahuman’s user base, with health-focused subscriptions and services contributing around 16% of revenue and Blood Vision about 5–6%.

Ultrahuman’s annualized revenue runs near $150 million; subscriptions and health services total roughly 21–22% of revenue, with hardware making up the rest.

The user base’s gender composition underscores strong demand for women’s health features and related services.